Capitolul 11 - BIBLIOGRAFIE - Ghid din 2019 privind hipertensiunea asociată sarcinii

M.Of. 738 bis

În vigoare

Versiune de la: 10 Septembrie 2019

CAPITOLUL 11:BIBLIOGRAFIE

SECŢIUNEA 1:Evaluare şi diagnostic

(1)Definiţii

1.Mark A. Brown, Laura A. Magee, Louise C. Kenny, S. Ananth Karumanchi, Fergus P McCarthy, Shigeru Saito, David R. Hall, Charlotte E. Warren, Gloria Adoyi, Salisu Ishaku. The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice. Brown, M., Pregnancy Hypertension (2018), https://doi.org/10.1016/j.preghy.2018.05.004.

2.European Society of Cardiology, ESC Clinical Practice Guidelines. Cardiovascular Diseases during Pregnancy (Management of). European Heart Journal 2018 doi:10.1093/eurheartj/ehy340.

3.Working group report on high blood pressure in pregnancy. National Instititutes of Health, Washington, DC 2000.Am J Obstet Gynecol 2000; 183: S1-S22.

4.Hughes EC (ed): Obstetric-Gynecologic Terminology. Philadelphia, FA DAvis, 1972, pp 422-423.

5.American College of Obstetrics and Gynecologists, ACOG Practice Bulletin No. 202. Gestational Hypertension and Preeclampsia. Obstetrics & Gynecology: January 2019 - Volume 133 - Issue 1 - p e1-e25. doi: 10.1097/AOG.0000000000003018.Report of th eNational Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000; 183:S1-S22.

6.Karlijn Corien Vollebregt, Kees Boer, Joris A. M. Van Der Post, Hans Wolf. Association of three different techniques to measure blood pressure in the first trimester with the development of hypertensive disorders of pregnancy. Acta Obstetricia et Gynecologica Scandinavica 2013 Nordic Federation of Societies of Obstetrics and Gynecology 92 (2013) 53-60.

(2)Investigaţii diagnostice

1.Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000; 183: S1-S22 Level III.

2.European Society of Cardiology, ESC Clinical Practice Guidelines. Cardiovascular Diseases during Pregnancy (Management of). European Heart Journal 2018 doi:10.1093/eurheartj/ehy340.

3.Sibai, BM. Magnesium sulfate prophylaxis in preeclampsia: Lessons learned from recent trials. Am J Obstet Gynecol 2004; 190:1520.

4.Milne, F, Redman, C, Walker, J, et al. The pre-eclampsia community guideline(PRECOG): how to screen for and detect onset of pre-eclampsia in the community. BMJ 2005; 330:576.

5.Duckitt, K, Harrington, D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ 2005; 330:565.

6.A. Atallah, E. Lecarpentier, F. Goffinet, M. Doret-Dion, P. Gaucherand, V. Tsatsaris. Aspirin for Prevention of Preeclampsia. Drugs (2017) 77:1819-1831. DOI 10.1007/s40265-017-0823-0.

7.Karlijn Corien Vollebregt, Kees Boer, Joris A. M. Van Der Post, Hans Wolf. Association of three different techniques to measure blood pressure in the first trimester with the development of hypertensive disorders of pregnancy. Acta Obstetricia et Gynecologica Scandinavica 2013 Nordic Federation of Societies of Obstetrics and Gynecology 92 (2013) 53-60.

8.Kjell Haram, Einar Svendsen, Ulrich Abildgaard. The HELLP syndrome: Clinical issues and management. AReview. BMC Pregnancy and Childbirth 2009, 9:8 doi:10.1186/1471-2393-9-8.Wolfberg, AJ, Lee-Parritz, A, Peller, AJ, Lieberman, ES. Association of Rheumatologic Disease With Preeclampsia. Obstet Gynecol 2004; 103:1190.

9.Mark A. Brown, Laura A. Magee, Louise C. Kenny, S. Ananth Karumanchi, Fergus P McCarthy, Shigeru Saito, David R. Hall, Charlotte E. Warren, Gloria Adoyi, Salisu Ishaku. The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice. Brown, M., Pregnancy Hypertension (2018), https://doi.org/10.1016/j.preghy.2018.05.004.

10.American College of Obstetrics and Gynecologists, ACOG Practice Bulletin No. 202. Gestational Hypertension and Preeclampsia. Obstetrics & Gynecology: January 2019 - Volume 133 - Issue 1 - p e1-e25. doi: 10.1097/AOG.0000000000003018.Report of th eNational Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000; 183:S1-S22.

11.Lain, KY, Roberts, JM. Contemporary concepts of the pathogenesis and management of preeclampsia. JAMA 2002; 287:3183.

12.Xiong, X, Fraser, WD, Demianczuk, NN. History of abortion, preterm, term birth, and risk of preeclampsia: A population-based study. Am J Obstet Gynecol 2002; 187:1013.

13.James N. Martin Jr, Justin M. Brewer, Kedra Wallace, Imran Sunesara, Ashley Canizaro, Pamela G. Blake, Babbette LaMarca, Michelle Y. Owens. Hellp syndrome and composite major maternal morbidity: importance of Mississippi classification system. J Matern Fetal Neonatal Med, 2013; 26(12): 1201-1206.

14.Dawson, LM, Parfrey, PS, Hefferton, D, et al. Familial risk of preeclampsia in newfoundland: a population-based study. J Am Soc Nephrol 2002; 13:1901.

15.Nilsson, E, Salonen Ros, H, Cnattingius, S, Lichtenstein, P. The importance of genetic and environmental effects for pre-eclampsia and gestational hypertension: a family study. BJOG 2004; 111:200.

16.Sibai, BM, Ewell, RJ, Levine, RJ, et al. Risk factors associated with preeclampsia in healthy nulliparous women. Am J Obstet Gynecol 1997; 177:1003.

17.Sibai, BM, Ramadan, MK, Chari, RS, Friedman, SA. Pregnancies complicated by HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): Subsequent pregnancy outcome and long-term prognosis. Am J Obstet Gynecol 1995; 172:125.

18.van Pampus, MG, Wolf, H, Mayruhu, G, et al. Long-term follow-up in patients with a history of (H)ELLP syndrome. Hypertens Pregnancy 2001; 20:15.

19.Garovic VD. Hypertension in pregnancy: diagnosis and treatment. Mayo Clin Proc 2000; 75/1071-1076

20.Magee, LA, Cham, C, Waterman, EJ, et al. Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis. BMJ 2003; 327:955.

21.Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000; 183: S1-S22 Level III

22.Campbell, DM, MacGillivray, I. Preeclampsia in second pregnancy. Br J Obstet Gynaecol 1985; 92:131.

23.Powers, RW, Bodnar, LM, Ness, RB, et al. Uric acid concentrations in early pregnancy among preeclamptic women with gestational hyperuricemia at delivery. Am J Obstet Gynecol 2006; 194:160.

24.American College of Obstetricians and Gynecologists. Chronic hypertension in pregnancy. ACOG practice bulletin #29. American College of Obstetricians and Gynecologists, Washington, DC 2001

25.Sibai, BM. Chronic hypertension in pregnancy. Obstet Gynecol 2002; 100:369.

26.Xiong, X, Fraser, WD, Demianczuk, NN. History of abortion, preterm, term birth, and risk of preeclampsia: A population-based study. Am J Obstet Gynecol 2002; 187:1013.

27.Dawson, LM, Parfrey, PS, Hefferton, D, et al. Familial risk of preeclampsia in newfoundland: a population-based study. J Am Soc Nephrol 2002; 13:1901.

28.Barton, JR, O'Brien, JM, Bergauer, NK, et al. Mild gestational hypertension remote from term: Progression and outcome. Am J Obstet Gynecol 2001; 184:979.

29.Buchbinder, A, Sibai, BM, Caritis, S, et al. Adverse perinatal outcomes are significantly higher in severe gestational hypertension than in mild preeclampsia. Am J Obstet Gynecol 2002; 186:66.

30.Hauth, JC, Ewell, MG, Levine, RJ, et al. Pregnancy outcomes in healthy nulliparas who developed hypertension. Calcium for Preeclampsia Prevention Study Group. Obstet Gynecol 2000; 95:24.

31.Cunningham FG, Grant NF, Leveno KJ, et al (eds): Hypertensive disorders in pregnancy. In |Williams Obstetrics, 21st ed. New York, McGraw-Hill, 2001, pp 567-618

32.Bricker L, Neilson JP: Routine ultrasound in late pregnancy (after 24 weeks): Cochrane Review. In The Cochrane Library, Issue 3. Oxford, UK, Update Software, 2003

33.McKenna D, Tharmaratnam S, Mahsud S, et al: A randomized trial using ultrasound to identify the high risk fetus in a low-risk population. Obstet Gynecol 2003; 101:626-632

34.Chauban SP, Sanderson M, Hendrix NW, et al: Perinatal outcome and amniotic fluid index in the antepartum and intrapartum: A meta-analysis. Am J Obstet Gynecol 1999; 181:1473-1478

35.Bricker L, Neilson JP: Routine Doppler ultrasound in pregnancy: Cochrane Review. In: The Cochrane Library, Issue 3. Oxford, UK, Update Software, 2003

(3)Diagnosticul formei severe de preeclampsie

1.Barton, JR, O'Brien, JM, Bergauer, NK, et al. Mild gestational hypertension remote from term: Progression and outcome. Am J Obstet Gynecol 2001; 184:979.

2.American College of Obstetrics and Gynecologists, ACOG Practice Bulletin No. 202. Gestational Hypertension and Preeclampsia. Obstetrics & Gynecology: January 2019 - Volume 133 - Issue 1 - p e1-e25. doi: 10.1097/AOG.0000000000003018.Report of th eNational Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000; 183:S1-S22.

3.European Society of Cardiology, ESC Clinical Practice Guidelines. Cardiovascular Diseases during Pregnancy (Management of). European Heart Journal 2018 doi:10.1093/eurheartj/ehy340.

4.Hauth, JC, Ewell, MG, Levine, RJ, et al. Pregnancy outcomes in healthy nulliparas who developed hypertension. Calcium for Preeclampsia Prevention Study Group. Obstet Gynecol 2000; 95:24.

5.Mark A. Brown, Laura A. Magee, Louise C. Kenny, S. Ananth Karumanchi, Fergus P McCarthy, Shigeru Saito, David R. Hall, Charlotte E. Warren, Gloria Adoyi, Salisu Ishaku. The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice. Brown, M., Pregnancy Hypertension (2018), https://doi.org/10.1016/j.preghy.2018.05.004.

SECŢIUNEA 2:Predicţie

1.Poon LC, Kametas NA, Chelemen T, Leal A, Nicolaides KH. Maternal risk factors for hypertensive disorders in preg- nancy: a multivariate approach. J Hum Hypertens 2010; 24:104-10.

2.Rolnik DL, Wright D, Poon LCY, Syngelaki A, O'Gorman N, de Paco Matallana C, Akolekar R, Cicero S, Janga D, Singh M, Molina FS, Persico N, Jani JC, Plasencia W, Papaioannou G, Tenenbaum-Gavish K, Nicolaides KH. ASPRE trial: performance of screening for preterm pre-eclampsia. Ultrasound Obstet Gynecol. 2017.

3.Rana S, Powe CE, Salahuddin S, Verlohren S, Perschel FH, Levine RJ, et al. Angiogenic factors and the risk of adverse outcomes in women with suspected preeclamp- sia. Circulation 2012; 125:911-9.

4.American College of Obstetrics and Gynecologists, ACOG Practice Bulletin No. 202. Gestational Hypertension and Preeclampsia. Obstetrics & Gynecology: January 2019 - Volume 133 - Issue 1 - p e1-e25. doi: 10.1097/AOG.0000000000003018.Report of th eNational Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000; 183:S1-S22.

5.European Society of Cardiology, ESC Clinical Practice Guidelines. Cardiovascular Diseases during Pregnancy (Management of). European Heart Journal 2018 doi:10.1093/eurheartj/ehy340.

SECŢIUNEA 3:Prevenţie

1.Roberge S, Bujold E, Nicolaides KH. Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis. Am J Obstet Gynecol. 2018 Mar; 218(3):287-293.e1. doi: 10.1016/j.ajog.2017.11.561. Epub 2017 Nov 11.

2.Bujold E, Tapp S, Audibert F, Ferreira E, Forest JC, Rey E, Fraser WD, Chaillet N, Giguere Y. Prevention of adverse pregnancy outcomes with low-dose ASA in early pregnancy: new perspectives for future randomized trials. J Obstet Gynaecol Can. 2011 May; 33(5):480-483

3.Rolnik DL, Wright D, Poon LC, O'Gorman N, Syngelaki A, de Paco Matallana C, Akolekar R, Cicero S, Janga D, Singh M, Molina FS, Persico N, Jani JC, Plasencia W, Papaioannou G, Tenenbaum-Gavish K, Meiri H, Gizurarson S, Maclagan K, Nicolaides KH. Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia. N Engl J Med. 2017 Aug 17; 377(7):613-622.

5.European Society of Cardiology, ESC Clinical Practice Guidelines. Cardiovascular Diseases during Pregnancy (Management of). European Heart Journal 2018 doi:10.1093/eurheartj/ehy340.

6.Dodd JM, McLeod A, Windrim RC et al. (2010) Antithrombotic therapy for improving maternal or infant health outcomes in women considered at risk of placental dysfunction. Cochrane Database of Systematic Reviews issue 6: CD006780.

SECŢIUNEA 4:Conduită

(1)Conduita în cazul formelor uşoare de preeclampsie

1.European Society of Cardiology, ESC Clinical Practice Guidelines. Cardiovascular Diseases during Pregnancy (Management of). European Heart Journal 2018 doi:10.1093/eurheartj/ehy340.

3.Mark A. Brown, Laura A. Magee, Louise C. Kenny, S. Ananth Karumanchi, Fergus P McCarthy, Shigeru Saito, David R. Hall, Charlotte E. Warren, Gloria Adoyi, Salisu Ishaku. The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice. Brown, M., Pregnancy Hypertension (2018), https://doi.org/10.1016/j.preghy.2018.05.004.James DK, Steer PJ, Weiner CP, Gonik B. High Risk Pregnancy - Management Options. Saunders 2005- third edition 36-772-809.

4.Kroner C, Turnbull D, Wilkinson C: Antenatal day care units versus hospital admission for women with complicated pregnancy. Cochrane Database Syst Rev 2001: CD0011803.

5.Kjell Haram, Einar Svendsen, Ulrich Abildgaard. The HELLP syndrome: Clinical issues and management. AReview. BMC Pregnancy and Childbirth 2009, 9:8 doi:10.1186/1471-2393-9-8.

6.Lewington, S, Clarke, R, Qizilbash, N, et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360:1903.

(2)Conduita medicală conservatoare în formele severe de preeclampsie

1.European Society of Cardiology, ESC Clinical Practice Guidelines. Cardiovascular Diseases during Pregnancy (Management of). European Heart Journal 2018 doi:10.1093/eurheartj/ehy340.

4.Stephanie Roberge, Kypros Nicolaides, Suzanne Demers, Jon Hyett, Nils Chaillet, Emmanuel Bujold. The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis. American Journal of Obstetrics & Gynecology, FEBRUARY 2017, page 110.

5.James N. Martin Jr, Justin M. Brewer, Kedra Wallace, Imran Sunesara, Ashley Canizaro, Pamela G. Blake, Babbette LaMarca, Michelle Y. Owens. Hellp syndrome and composite major maternal morbidity: importance of Mississippi classification system. J Matern Fetal Neonatal Med, 2013; 26(12): 1201-1206.

6.A. Atallah, E. Lecarpentier, F. Goffinet, M. Doret-Dion, P. Gaucherand, V. Tsatsaris. Aspirin for Prevention of Preeclampsia. Drugs (2017) 77:1819-1831. DOI 10.1007/s40265-017-0823-0.

7.Schiff, E, Friedman, SA, Kao, L, Sibai, BM. The importance of urinary protein excretion during conservative management of severe preeclampsia. Am J Obstet Gynecol 1996; 175:1313.

8.Hall, DR, Odendaal, HJ, Steyn, DW, Grive, D. Urinary protein excretion and expectant management of early onset, severe preeclampsia. Int J Gynaecol Obstet 2002; 77:1.

9.Hall, DR, Odendaal, HJ, Steyn, DW, Grive, D. Urinary protein excretion and expectant management of early onset, severe preeclampsia. Int J Gynaecol Obstet 2002; 77:1.

10.Chang, EY, Menard, MK, Vermillion, ST, et al. The association between hyaline membrane disease and preeclampsia. Am J Obstet Gynecol 2004; 191:1414.

11.Chammas, MF, Nguyen, TM, Li, MA, et al. Expectant management of severe preterm preeclampsia: is intrauterine growth restriction an indication for immediate delivery?. Am J Obstet Gynecol 2000; 183:853.

12.Buchbinder, A, Sibai, BM, Caritis, S, et al. Adverse perinatal outcomes are significantly higher in severe gestational hypertension than in mild preeclampsia. Am J Obstet Gynecol 2002; 186:66.

13.Hauth, JC, Ewell, MG, Levine, RJ, et al. Pregnancy outcomes in healthy nulliparas who developed hypertension. Calcium for Preeclampsia Prevention Study Group. Obstet Gynecol 2000; 95:24.

14.Barton, JR, O'Brien, JM, Bergauer, NK, et al. Mild gestational hypertension remote from term: Progression and outcome. Am J Obstet Gynecol 2001; 184:979.

15.James DK, Steer PJ, Weiner CP, Gonik B. High Risk Pregnancy- Management Options. Saunders 2005- third edition.

16.Hall, DR, Odendaal, HJ, Steyn, DW, Grove, D. Expectant management of early onset, severe pre-eclampsia: maternal outcome. BJOG 2000; 107:1252.

17.Haddad, B, Deis, S, Goffinet, F, et al. Maternal and perinatal outcomes during expectant management of 239 severe preeclamptic women between 24 and 33 weeks' gestation. Am J Obstet Gynecol 2004; 190:1590.

(3)Tratamentul antihipertensiv în preeclampsie

1.CunninghamFG, Gant NF, Leveno KL, et al: Hypertensive disorders in pregnancy. In Williams Obstetrics, 21^st ed. New York, McGraw-Hill, 2001, pp 567-618

2.Report of th eNational Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000; 183:S1-S22

3.European Society of Cardiology, ESC Clinical Practice Guidelines. Cardiovascular Diseases during Pregnancy (Management of). European Heart Journal 2018 doi:10.1093/eurheartj/ehy340.

5.Haddad, B, Deis, S, Goffinet, F, et al. Maternal and perinatal outcomes during expectant management of 239 severe preeclamptic women between 24 and 33 weeks' gestation. Am J Obstet Gynecol 2004; 190:1590.

6.Mark A. Brown, Laura A. Magee, Louise C. Kenny, S. Ananth Karumanchi, Fergus P McCarthy, Shigeru Saito, David R. Hall, Charlotte E. Warren, Gloria Adoyi, Salisu Ishaku. The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice. Brown, M., Pregnancy Hypertension (2018), https://doi.org/10.1016/j.preghy.2018.05.004.Working group report on high blood pressure in pregnancy. National Instititutes of Health, Washington, DC 2000. 390-396.

7.Lewington, S, Clarke, R, Qizilbash, N, et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360:1903.

8.Sibai, BM. Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol 2003; 102:181.

9.Martin, JN Jr, Thigpen, BD, Moore, RC, et al. Stroke and severe preeclampsia and eclampsia: a paradigm shift focusing on systolic blood pressure. Obstet Gynecol 2005; 105:246.

10.von Dadelszen, P, Magee, LA. Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: an updated metaregression analysis. J Obstet Gynaecol Can 2002; 24:941.

11.Lydakis, C, Lip, GY, Beevers, M, Beevers, DG. Atenolol and fetal growth in pregnancies complicated by hypertension. Am J Hypertens 1999; 12:541.

12.Sibai, BM. Chronic hypertension in pregnancy. Obstet Gynecol 2002; 100:369.

13.Magee LA, Elran E, Bull SB, et al: Risks and benefits of betareceptor blockers for pregnancy hypertension: Overview of the randomized trials. Eur J Obstet Gynecol Reprod Biol 2000; 88:15-26.

14.Podymow, T, August, P, Umans, JG. Antihypertensive therapy in pregnancy. Semin Nephrol 2004; 24:616.

15.Smith, P, Anthony, J, Johanson, R. Nifedipine in pregnancy. BJOG 2000; 107:299.

16.Cooper, WO, Hernandez-Diaz, S, Arbogast, PG, et al. Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med 2006; 354:2443.

(4)Tratamentul antihipertensiv al formei acute de HTA

1.European Society of Cardiology, ESC Clinical Practice Guidelines. Cardiovascular Diseases during Pregnancy (Management of). European Heart Journal 2018 doi:10.1093/eurheartj/ehy340.

2.Magee, LA, Cham, C, Waterman, EJ, et al. Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis. BMJ 2003; 327:955.

3.American College of Obstetrics and Gynecologists, ACOG Practice Bulletin No. 202. Gestational Hypertension and Preeclampsia. Obstetrics & Gynecology: January 2019 - Volume 133 - Issue 1 - p e1-e25. doi: 10.1097/AOG.0000000000003018.Report of th eNational Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000; 183:S1-S22.

4.Mark A. Brown, Laura A. Magee, Louise C. Kenny, S. Ananth Karumanchi, Fergus P McCarthy, Shigeru Saito, David R. Hall, Charlotte E. Warren, Gloria Adoyi, Salisu Ishaku. The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice. Brown, M., Pregnancy Hypertension (2018), https://doi.org/10.1016/j.preghy.2018.05.004.

5.Kjell Haram, Einar Svendsen, Ulrich Abildgaard. The HELLP syndrome: Clinical issues and management. AReview. BMC Pregnancy and Childbirth 2009, 9:8 doi:10.1186/1471-2393-9-8.

6.James N. Martin Jr, Justin M. Brewer, Kedra Wallace, Imran Sunesara, Ashley Canizaro, Pamela G. Blake, Babbette LaMarca, Michelle Y. Owens. Hellp syndrome and composite major maternal morbidity: importance of Mississippi classification system. J Matern Fetal Neonatal Med, 2013; 26(12): 1201-1206.

7.Magee LA, Elran E, Bull SB, et al: Risks and benefits of betareceptor blockers for pregnancy hypertension: Overview of the randomized trials. Eur J Obstet Gynecol Reprod Biol 2000; 88:15-26

(5)Conduita în criza eclamptică

1.Sibai, BM. Diagnosis, prevention, and management of eclampsia. Obstet Gynecol 2005; 105:402.

2.European Society of Cardiology, ESC Clinical Practice Guidelines. Cardiovascular Diseases during Pregnancy (Management of). European Heart Journal 2018 doi:10.1093/eurheartj/ehy340.

5.Kjell Haram, Einar Svendsen, Ulrich Abildgaard. The HELLP syndrome: Clinical issues and management. AReview. BMC Pregnancy and Childbirth 2009, 9:8 doi:10.1186/1471-2393-9-8.

(6)Terapia anticonvulsivantă

1.Hall, DR, Odendaal, HJ, Steyn, DW, Grove, D. Expectant management of early onset, severe pre-eclampsia: maternal outcome. BJOG 2000; 107:1252.

3.Duley, L, Gulmezoglu, AM. Magnesium sulphate versus lytic cocktail for eclampsia. Cochrane Database Syst Rev 2001; :CD002960.

4.Tuffnell, DJ, Jankowicz, D, Lindow, SW, et al. Outcomes of severe pre-eclampsia/eclampsia in Yorkshire 1999/2003. BJOG 2005; 112:875.

5.Sibai, BM. Diagnosis, prevention, and management of eclampsia. Obstet Gynecol 2005; 105:402

6.Sibai, BM. Magnesium sulfate prophylaxis in preeclampsia: Lessons learned from recent trials. Am J Obstet Gynecol 2004; 190:1520.

7.Hall, DR, Odendaal, HJ, Smith, M. Is the prophylactic administration of magnesium sulphate in women with pre-eclampsia indicated prior to labour?. BJOG 2000; 107:903.

8.Isler, CM, Barrilleaux, PS, Rinehart, BK, et al. Repeat postpartum magnesium sulfate administration for seizure prophylaxis: is there a patient profile predictive of need for additional therapy?. J Matern Fetal Neonatal Med 2002; 11:75.

9.Isler, CM, Barrilleaux, PS, Rinehart, BK, et al. Postpartum seizure prophylaxis: using maternal clinical parameters to guide therapy. Obstet Gynecol 2003; 101:66.

10.Fontenot, MT, Lewis, DF, Frederick, JB, et al. A prospective randomized trial of magnesium sulfate in severe preeclampsia: Use of diuresis as a clinical parameter to determine the duration of postpartum therapy. Am J Obstet Gynecol 2005; 192:1788.

11.Sibai, BM. Magnesium sulfate prophylaxis in preeclampsia: Lessons learned from recent trials. Am J Obstet Gynecol 2004; 190:1520

(7)Protocol de administrare a sulfatului de magneziu

1.Witlin, AG, Sibai, BM. Magnesium sulfate therapy in preeclampsia and eclampsia. Obstet Gynecol 1998; 92:883.

2.The eclampsia Trial Collaborative Group: Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia trial. LAncet 1995; 345:1455-1463

3.Coetzee EJ, Dommisse J, Anthony J: A randomized controlled trial of intravenous magnesium sulphate versus placebo in management of women with severe preeclampsia. BJOG 1998; 105:300-303

4.Witlin AG, Sibai BM: MAgnesium sulfate therapy in preeclampsia and eclampsia. Obstet Gynecol 1998; 92:883-889

5.Lucas MJ, Leveno KJ, Cunningham FG: A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia. N Engl J Med 1995; 333:201-205

6.American College of Obstetrics and Gynecologists, ACOG Practice Bulletin No. 202. Gestational Hypertension and Preeclampsia. Obstetrics & Gynecology: January 2019 - Volume 133 - Issue 1 - p e1-e25. doi: 10.1097/AOG.0000000000003018.Report of th eNational Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000; 183:S1-S22.

7.Mark A. Brown, Laura A. Magee, Louise C. Kenny, S. Ananth Karumanchi, Fergus P McCarthy, Shigeru Saito, David R. Hall, Charlotte E. Warren, Gloria Adoyi, Salisu Ishaku. The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice. Brown, M., Pregnancy Hypertension (2018), https://doi.org/10.1016/j.preghy.2018.05.004.

8.Koontz, SL, Friedman, SA, Schwartz, ML. Symptomatic hypocalcemia after tocolytic therapy with magnesium sulfate and nifedipine. Am J Obstet Gynecol 2004; 190:1773.

9.Ganzevoort, JW, Hoogerwaard, EM, van der, Post JA. [Hypocalcemic delirium due to magnesium sulphate therapy in a pregnant woman with pre-eclampsia]. Ned Tijdschr Geneeskd 2002; 146:1453.

10.European Society of Cardiology, ESC Clinical Practice Guidelines. Cardiovascular Diseases during Pregnancy (Management of). European Heart Journal 2018 doi:10.1093/eurheartj/ehy340.

(8)Naşterea în sarcinile complicate cu preeclampsie

1.Coppage, KH, Polzin, WJ. Severe preeclampsia and delivery outcomes: Is immediate cesarean delivery beneficial?. Am J Obstet Gynecol 2002; 186:921.

2.European Society of Cardiology, ESC Clinical Practice Guidelines. Cardiovascular Diseases during Pregnancy (Management of). European Heart Journal 2018 doi:10.1093/eurheartj/ehy340.

5.Kjell Haram, Einar Svendsen, Ulrich Abildgaard. The HELLP syndrome: Clinical issues and management. AReview. BMC Pregnancy and Childbirth 2009, 9:8 doi:10.1186/1471-2393-9-8.

6.Report of th eNational Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000; 183:S1-S22.

7.Cunningham FG, Grant NF, Leveno KJ, et al (eds): Hypertensive disorders in pregnancy. In |Williams Obstetrics, 21^st ed. New York, McGraw-Hill, 2001, pp 567-618.

8.Stephanie Roberge, Kypros Nicolaides, Suzanne Demers, Jon Hyett, Nils Chaillet, Emmanuel Bujold. The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis. American Journal of Obstetrics & Gynecology, FEBRUARY 2017, page 110.

9.Karlijn Corien Vollebregt, Kees Boer, Joris A. M. Van Der Post, Hans Wolf. Association of three different techniques to measure blood pressure in the first trimester with the development of hypertensive disorders of pregnancy. Acta Obstetricia et Gynecologica Scandinavica 2013 Nordic Federation of Societies of Obstetrics and Gynecology 92 (2013) 53-60.

10.A. Atallah, E. Lecarpentier, F. Goffinet, M. Doret-Dion, P. Gaucherand, V. Tsatsaris. Aspirin for Prevention of Preeclampsia. Drugs (2017) 77:1819-1831. DOI 10.1007/s40265-017-0823-0.

11.Mayan, H, Hourvitz, A, Schiff, E, Farfel, Z. Symptomatic hypocalcaemia in hypermagnesaemia-induced hypoparathyroidism, during magnesium tocolytic therapy--possible involvement of the calcium-sensing receptor. Nephrol Dial Transplant 1999; 14:1764.

12.Jenkins, SM, Head, BB, Hauth, JC. Severe preeclampsia at less than 25 weeks of gestation: Maternal and neonatal outcomes. Am J Obstet Gynecol 2002; 186:790.

13.Martin, JN Jr, Thigpen, BD, Moore, RC, et al. Stroke and severe preeclampsia and eclampsia: a paradigm shift focusing on systolic blood pressure. Obstet Gynecol 2005; 105:246.

14.Chang, EY, Menard, MK, Vermillion, ST, et al. The association between hyaline membrane disease and preeclampsia. Am J Obstet Gynecol 2004; 191:1414.

15.WHO Department of Reproductive Health and Research - Managing Complications in Pregnancy and Childbirth 2005 S34-S50

SECŢIUNEA 5:Urmărire şi monitorizare

1.European Society of Cardiology, ESC Clinical Practice Guidelines. Cardiovascular Diseases during Pregnancy (Management of). European Heart Journal 2018 doi:10.1093/eurheartj/ehy340.

4.Kjell Haram, Einar Svendsen, Ulrich Abildgaard. The HELLP syndrome: Clinical issues and management. AReview. BMC Pregnancy and Childbirth 2009, 9:8 doi:10.1186/1471-2393-9-8.

5.Stephanie Roberge, Kypros Nicolaides, Suzanne Demers, Jon Hyett, Nils Chaillet, Emmanuel Bujold. The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis. American Journal of Obstetrics & Gynecology, FEBRUARY 2017, page 110.Bricker L, Neilson JP: Routine ultrasound in late pregnancy (after 24 weeks): Cochrane Review. In The Cochrane Library, Issue 3. Oxford, UK, Update Software, 2003.

6.Hall, DR, Odendaal, HJ, Steyn, DW, Grove, D. Expectant management of early onset, severe pre-eclampsia: maternal outcome. BJOG 2000; 107:1252.

7.Haddad, B, Deis, S, Goffinet, F, et al. Maternal and perinatal outcomes during expectant management of 239 severe preeclamptic women between 24 and 33 weeks' gestation. Am J Obstet Gynecol 2004; 190:1590.

8.Bricker L, Neilson JP: Routine Doppler ultrasound in pregnancy: Cochrane Review. In: The Cochrane Library, Issue 3. Oxford, UK, Update Software, 2003.